Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - NET CHANGE IN CASH
Net Change in Cash ESPR - Esperion Therapeutics, Inc.
-42.5 M
LAST VALUE
3.92%
2 YEAR CAGR
-78.21%
5 YEAR CAGR
-6.35%
10 YEAR CAGR